Viva la resolution!

Malas et  al, in their study reporting in-hospital outcomes after transcarotid artery revascularization (TCAR) vs transfemoral carotid artery stenting (TFCAS) in the Society for Vascular Surgery Vascular Quality Initiative TCAR Surveillance Project, concluded that “this is the first study to demonstrate t he benefit of TCAR compared with TFCAS in real-world practice.”1 At first sight, this is welcome news, as (intuitively) it seems logical that any carotid artery stenting (CAS) innovation that avoids negotiating the aortic arch and uses temporary flow reversal for cerebral protection during stent p lacement has the potential to considerably reduce procedural stroke.

Source: Journal of Vascular Surgery - June 20, 2019 Category: Surgery Authors: A. Ross Naylor Tags: Letter to the Editor Source Type: research